107 related articles for article (PubMed ID: 27075636)
21. Risk of radiation retinopathy in patients with orbital and ocular lymphoma.
Kaushik M; Pulido JS; Schild SE; Stafford S
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1145-50. PubMed ID: 22592046
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
23. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy.
Berenbom A; Davila RM; Lin HS; Harbour JW
Eye (Lond); 2007 Sep; 21(9):1198-201. PubMed ID: 16732210
[TBL] [Abstract][Full Text] [Related]
25. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
Gandhi PD; Fleming JC; Haik BG; Wilson MW
Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
[TBL] [Abstract][Full Text] [Related]
26. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients.
Duthoy W; Boterberg T; Claus F; Ost P; Vakaet L; Bral S; Duprez F; Van Landuyt M; Vermeersch H; De Neve W
Cancer; 2005 Jul; 104(1):71-82. PubMed ID: 15915466
[TBL] [Abstract][Full Text] [Related]
27. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
28. Severe retinopathy following radiation therapy with a moderate dose for orbital mucosa-associated lymphoid tissue lymphoma.
Hata M; Kaneko A; Tomita N; Inoue T
Hematol Oncol; 2014 Dec; 32(4):212-4. PubMed ID: 25471380
[TBL] [Abstract][Full Text] [Related]
29. Primary intraocular lymphoma: improving the diagnostic procedure.
Karma A; von Willebrand EO; Tommila PV; Paetau AE; Oskala PS; Immonen IJ
Ophthalmology; 2007 Jul; 114(7):1372-7. PubMed ID: 17324466
[TBL] [Abstract][Full Text] [Related]
30. Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy.
Prabhu RS; Kandula S; Liebman L; Wojno TH; Hayek B; Hall WA; Shu HK; Crocker I
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):643-9. PubMed ID: 22836055
[TBL] [Abstract][Full Text] [Related]
31. Ocular complications of high-dose radiotherapy.
Brady LW
Oncology (Williston Park); 1996 Jul; 10(7):981-2, 984. PubMed ID: 8837116
[TBL] [Abstract][Full Text] [Related]
32. Preliminary results of radiotherapy for primary intraocular non-Hodgkin lymphoma.
Mikami R; Nakayama H; Goto H; Kimura K; Usui Y; Nogi S; Tajima Y; Okubo M; Kanesaka N; Sugahara S; Tokuuye K
Leuk Lymphoma; 2013 Oct; 54(10):2181-4. PubMed ID: 23343177
[TBL] [Abstract][Full Text] [Related]
33. Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94).
Ghadjar P; Simcock M; Zimmermann F; Betz M; Bodis S; Bernier J; Studer G; Aebersold DM;
Radiother Oncol; 2012 Aug; 104(2):213-8. PubMed ID: 22726581
[TBL] [Abstract][Full Text] [Related]
34. Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.
Paik JS; Cho WK; Lee SE; Choi BO; Jung SE; Park GS; Kim SH; Yang SW; Cho SG
Ann Hematol; 2012 Sep; 91(9):1393-401. PubMed ID: 22543827
[TBL] [Abstract][Full Text] [Related]
35. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
36. Primary intraocular lymphoma.
Sagoo MS; Mehta H; Swampillai AJ; Cohen VM; Amin SZ; Plowman PN; Lightman S
Surv Ophthalmol; 2014; 59(5):503-16. PubMed ID: 24560125
[TBL] [Abstract][Full Text] [Related]
37. [Intraocular lymphoma associated with primary malignant lymphoma of the central nervous system: Seven-year experience of a tertiary center].
Joubert R; Bonnin N; Kemeny JL; Moluçon-Chabrot C; Tournilhac O; Bacin F; Chiambaretta F
J Fr Ophtalmol; 2015 Jun; 38(6):559-66. PubMed ID: 25976140
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma.
Tran KH; Campbell BA; Fua T; MacManus M; Ryan G; Chesson B; Wirth A
Leuk Lymphoma; 2013 Mar; 54(3):491-6. PubMed ID: 23020137
[TBL] [Abstract][Full Text] [Related]
39. Meibomian Gland Dysfunction Associated With Periocular Radiotherapy.
Woo YJ; Ko J; Ji YW; Kim TI; Yoon JS
Cornea; 2017 Dec; 36(12):1486-1491. PubMed ID: 28902011
[TBL] [Abstract][Full Text] [Related]
40. Palliative radiation therapy for patients with orbital and ocular metastases.
Chik JYK; Leung CWL; Wong KH
Ann Palliat Med; 2020 Nov; 9(6):4458-4466. PubMed ID: 32156122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
